89 related articles for article (PubMed ID: 17551386)
1. Basic science for the clinician 44: atherosclerosis: an immunologically mediated (autoimmune?) disease.
Sigal LH
J Clin Rheumatol; 2007 Jun; 13(3):160-8. PubMed ID: 17551386
[TBL] [Abstract][Full Text] [Related]
2. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.
Hahn BH; Grossman J; Chen W; McMahon M
J Autoimmun; 2007; 28(2-3):69-75. PubMed ID: 17433865
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
4. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice.
She ZG; Zheng W; Wei YS; Chen HZ; Wang AB; Li HL; Liu G; Zhang R; Liu JJ; Stallcup WB; Zhou Z; Liu DP; Liang CC
Circ Res; 2009 May; 104(10):1160-8. PubMed ID: 19359600
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein, anti-C-reactive protein antibodies and clinical atherosclerosis.
Rosenau BJ; Costenbader KH; Schur PH
Vasc Med; 2008 Feb; 13(1):25-8. PubMed ID: 18372435
[TBL] [Abstract][Full Text] [Related]
6. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans.
Leitinger N
Subcell Biochem; 2008; 49():325-50. PubMed ID: 18751917
[TBL] [Abstract][Full Text] [Related]
7. Oxidation-specific epitopes are important targets of innate immunity.
Chou MY; Hartvigsen K; Hansen LF; Fogelstrand L; Shaw PX; Boullier A; Binder CJ; Witztum JL
J Intern Med; 2008 May; 263(5):479-88. PubMed ID: 18410591
[TBL] [Abstract][Full Text] [Related]
8. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
Loppnow H; Werdan K; Buerke M
Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
[TBL] [Abstract][Full Text] [Related]
9. Humoral mechanisms of atherogenesis.
Batuca JR; Amaral MC; Alves JD
Ann N Y Acad Sci; 2009 Sep; 1173():401-8. PubMed ID: 19758179
[TBL] [Abstract][Full Text] [Related]
10. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
Peters MJ; van Halm VP; Nurmohamed MT; Damoiseaux J; Tervaert JW; Twisk JW; Dijkmans BA; Voskuyl AE
J Rheumatol; 2008 Aug; 35(8):1495-9. PubMed ID: 18597411
[TBL] [Abstract][Full Text] [Related]
11. Determination of oxidized low-density lipoproteins (ox-LDL) versus ox-LDL/beta2GPI complexes for the assessment of autoimmune-mediated atherosclerosis.
Lopez LR; Buckner TR; Hurley BL; Kobayashi K; Matsuura E
Ann N Y Acad Sci; 2007 Aug; 1109():303-10. PubMed ID: 17785319
[TBL] [Abstract][Full Text] [Related]
12. Picrorhiza scrophulariiflora improves accelerated atherosclerosis through inhibition of redox-sensitive inflammation.
Guo ZJ; Hou FF; Liu SX; Tian JW; Zhang WR; Xie D; Zhou ZM; Liu ZQ; Zhang X
Int J Cardiol; 2009 Aug; 136(3):315-24. PubMed ID: 19178960
[TBL] [Abstract][Full Text] [Related]
13. Modeling immune system control of atherogenesis.
Pappalardo F; Musumeci S; Motta S
Bioinformatics; 2008 Aug; 24(15):1715-21. PubMed ID: 18556669
[TBL] [Abstract][Full Text] [Related]
14. Preventing autoimmune and infection triggered atherosclerosis for an enduring healthful lifestyle.
Matsuura E; Kobayashi K; Lopez LR
Autoimmun Rev; 2008 Jan; 7(3):214-22. PubMed ID: 18190881
[TBL] [Abstract][Full Text] [Related]
15. Free hemoglobin: a dangerous signal for the immune system in patients with carotid atherosclerosis?
Buttari B; Profumo E; Petrone L; Pietraforte D; Siracusano A; Margutti P; Delunardo F; Ortona E; Minetti M; Salvati B; Riganò R
Ann N Y Acad Sci; 2007 Jun; 1107():42-50. PubMed ID: 17804531
[TBL] [Abstract][Full Text] [Related]
16. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
Nilsson J; Fredrikson GN; Björkbacka H; Chyu KY; Shah PK
J Intern Med; 2009 Sep; 266(3):221-31. PubMed ID: 19702790
[TBL] [Abstract][Full Text] [Related]
17. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G
Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113
[TBL] [Abstract][Full Text] [Related]
18. The paradox of dysfunctional high-density lipoprotein.
Ansell BJ; Fonarow GC; Fogelman AM
Curr Opin Lipidol; 2007 Aug; 18(4):427-34. PubMed ID: 17620860
[TBL] [Abstract][Full Text] [Related]
19. Protein carbamylation links inflammation, smoking, uremia and atherogenesis.
Wang Z; Nicholls SJ; Rodriguez ER; Kummu O; Hörkkö S; Barnard J; Reynolds WF; Topol EJ; DiDonato JA; Hazen SL
Nat Med; 2007 Oct; 13(10):1176-84. PubMed ID: 17828273
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity in atherosclerosis: a protective response losing control?
Nilsson J; Hansson GK
J Intern Med; 2008 May; 263(5):464-78. PubMed ID: 18410590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
